Role of renin classification for diuretic treatment of black hypertensive patients

O. B. Holland, C. Gomez-Sanchez, C. Fairchild, N. M. Kaplan

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Previous studies in white and mixed-race hypertensive patient populations have generally found patients with low renin activity more responsive to diuretic therapy than patients with normal renin activity. Twenty-nine black patients (26 women and 3 men) with placebo diastolic blood pressure of 90 to 115 mm Hg were treated with spironolactone (100 to 400 mg/day) and hydrochlorothiazide (100/mg/day). Renin status was categorized by (1) the intravenous furosemide test, (2) ambulation during placebo, and (3) ambulation during spironolactone and hydrochlorothiazide treatment. Only 7 patients were categorized identically with all methods. No method identified a low renin subgroup that was more responsive to either spironolactone or hydrochlorothiazide. Diastolic blood pressure fall with hydrochlorothiazide (18 mm Hg) and 400 mg/day of spironolactone (15 mm Hg) was similar. Thus, since black women with both low and normal renin activity are quite responsive to diuretics, renin classification to guide initial antihypertensive selection is not warranted.

Original languageEnglish (US)
Pages (from-to)1365-1370
Number of pages6
JournalArchives of Internal Medicine
Volume139
Issue number12
DOIs
StatePublished - 1979

Fingerprint

Diuretics
Renin
Blood Pressure
Spironolactone
Hydrochlorothiazide
Walking
Therapeutics
Placebos
Furosemide
Antihypertensive Agents
Population

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Role of renin classification for diuretic treatment of black hypertensive patients. / Holland, O. B.; Gomez-Sanchez, C.; Fairchild, C.; Kaplan, N. M.

In: Archives of Internal Medicine, Vol. 139, No. 12, 1979, p. 1365-1370.

Research output: Contribution to journalArticle

Holland, O. B. ; Gomez-Sanchez, C. ; Fairchild, C. ; Kaplan, N. M. / Role of renin classification for diuretic treatment of black hypertensive patients. In: Archives of Internal Medicine. 1979 ; Vol. 139, No. 12. pp. 1365-1370.
@article{162f01aa2fdb49948c2960404451577f,
title = "Role of renin classification for diuretic treatment of black hypertensive patients",
abstract = "Previous studies in white and mixed-race hypertensive patient populations have generally found patients with low renin activity more responsive to diuretic therapy than patients with normal renin activity. Twenty-nine black patients (26 women and 3 men) with placebo diastolic blood pressure of 90 to 115 mm Hg were treated with spironolactone (100 to 400 mg/day) and hydrochlorothiazide (100/mg/day). Renin status was categorized by (1) the intravenous furosemide test, (2) ambulation during placebo, and (3) ambulation during spironolactone and hydrochlorothiazide treatment. Only 7 patients were categorized identically with all methods. No method identified a low renin subgroup that was more responsive to either spironolactone or hydrochlorothiazide. Diastolic blood pressure fall with hydrochlorothiazide (18 mm Hg) and 400 mg/day of spironolactone (15 mm Hg) was similar. Thus, since black women with both low and normal renin activity are quite responsive to diuretics, renin classification to guide initial antihypertensive selection is not warranted.",
author = "Holland, {O. B.} and C. Gomez-Sanchez and C. Fairchild and Kaplan, {N. M.}",
year = "1979",
doi = "10.1001/archinte.139.12.1365",
language = "English (US)",
volume = "139",
pages = "1365--1370",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Role of renin classification for diuretic treatment of black hypertensive patients

AU - Holland, O. B.

AU - Gomez-Sanchez, C.

AU - Fairchild, C.

AU - Kaplan, N. M.

PY - 1979

Y1 - 1979

N2 - Previous studies in white and mixed-race hypertensive patient populations have generally found patients with low renin activity more responsive to diuretic therapy than patients with normal renin activity. Twenty-nine black patients (26 women and 3 men) with placebo diastolic blood pressure of 90 to 115 mm Hg were treated with spironolactone (100 to 400 mg/day) and hydrochlorothiazide (100/mg/day). Renin status was categorized by (1) the intravenous furosemide test, (2) ambulation during placebo, and (3) ambulation during spironolactone and hydrochlorothiazide treatment. Only 7 patients were categorized identically with all methods. No method identified a low renin subgroup that was more responsive to either spironolactone or hydrochlorothiazide. Diastolic blood pressure fall with hydrochlorothiazide (18 mm Hg) and 400 mg/day of spironolactone (15 mm Hg) was similar. Thus, since black women with both low and normal renin activity are quite responsive to diuretics, renin classification to guide initial antihypertensive selection is not warranted.

AB - Previous studies in white and mixed-race hypertensive patient populations have generally found patients with low renin activity more responsive to diuretic therapy than patients with normal renin activity. Twenty-nine black patients (26 women and 3 men) with placebo diastolic blood pressure of 90 to 115 mm Hg were treated with spironolactone (100 to 400 mg/day) and hydrochlorothiazide (100/mg/day). Renin status was categorized by (1) the intravenous furosemide test, (2) ambulation during placebo, and (3) ambulation during spironolactone and hydrochlorothiazide treatment. Only 7 patients were categorized identically with all methods. No method identified a low renin subgroup that was more responsive to either spironolactone or hydrochlorothiazide. Diastolic blood pressure fall with hydrochlorothiazide (18 mm Hg) and 400 mg/day of spironolactone (15 mm Hg) was similar. Thus, since black women with both low and normal renin activity are quite responsive to diuretics, renin classification to guide initial antihypertensive selection is not warranted.

UR - http://www.scopus.com/inward/record.url?scp=0018564833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018564833&partnerID=8YFLogxK

U2 - 10.1001/archinte.139.12.1365

DO - 10.1001/archinte.139.12.1365

M3 - Article

C2 - 518220

AN - SCOPUS:0018564833

VL - 139

SP - 1365

EP - 1370

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 12

ER -